Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
about
Surgery for recurrent biliary carcinoma: results for 27 recurrent casesThe Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.Adjuvant treatment in biliary tract cancer: to treat or not to treat?Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
P2860
Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adjuvant chemotherapy for rese ...... t status and future direction.
@en
Adjuvant chemotherapy for rese ...... t status and future direction.
@nl
type
label
Adjuvant chemotherapy for rese ...... t status and future direction.
@en
Adjuvant chemotherapy for rese ...... t status and future direction.
@nl
prefLabel
Adjuvant chemotherapy for rese ...... t status and future direction.
@en
Adjuvant chemotherapy for rese ...... t status and future direction.
@nl
P2860
P1476
Adjuvant chemotherapy for rese ...... t status and future direction.
@en
P2093
Masaru Konishi
P2860
P2888
P304
P356
10.1007/S00534-011-0499-X
P577
2012-07-01T00:00:00Z